XNYS · Healthcare · Medical Instruments & Supplies
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | Q1 2026 | 1.35 | 1.48 | +9.63% | $2.01B | ✅ Beat | -2.79% | +8.78% | — |
| 2026-02-26 | Q4 2025 | 1.50 | 1.57 | +4.67% | $2.00B | ✅ Beat | -2.52% | -8.01% | -18.43% |
| 2025-11-06 |
| Q3 2025 |
| 1.43 |
| 1.50 |
| +4.90% |
| $2.10B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-07 | Q2 2025 | 1.45 | 1.69 | +16.55% | $2.16B | ✅ Beat | +4.99% | +1.74% | +1.07% |
| 2025-02-27 | Q4 2024 | 1.32 | 1.41 | +6.82% | $2.07B | ✅ Beat | -4.42% | -9.23% | -8.87% |
| 2024-11-07 | Q3 2024 | 1.39 | 1.64 | +17.99% | $2.08B | ✅ Beat | -3.52% | -9.55% | -5.91% |
Showing last 6 quarters.